Location History:
- Southborough, MA (US) (2017)
- Guangzhou, CN (2007 - 2022)
Company Filing History:
3 out of 2,967 
1 out of 12 
1 out of 1 Years Active: 2007-2022
Title: Innovations of Lisheng Peng
Introduction
Lisheng Peng is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of engineered botulinum neurotoxins. With a total of five patents to his name, Peng's work has the potential to impact various medical applications.
Latest Patents
Lisheng Peng's latest patents include innovative polypeptides related to botulinum neurotoxin (BoNT). One patent discloses a botulinum neurotoxin polypeptide with a modified receptor binding domain, featuring amino acid mutations that enhance the binding of the BoNT to its receptor. This invention includes isolated modified HC, polypeptides comprising the modified HC, chimeric molecules, pharmaceutical compositions, and methods for their use. Another patent focuses on BoNT polypeptides with a modified receptor binding domain of serotype B, detailing specific substitution mutations and combinations that improve functionality. These advancements open new avenues for therapeutic applications.
Career Highlights
Throughout his career, Lisheng Peng has worked with prestigious institutions, including Harvard College and Harvard Corporation. His research has contributed to the understanding and application of neurotoxins in medicine, showcasing his expertise in the field.
Collaborations
Lisheng Peng has collaborated with notable individuals such as Min Dong and Pål Erik Gustav Stenmark. These partnerships have further enriched his research and development efforts.
Conclusion
Lisheng Peng's innovative work in the field of biotechnology, particularly with engineered botulinum neurotoxins, highlights his significant contributions as an inventor. His patents reflect a commitment to advancing medical science and improving therapeutic options.